As far as their stock, I know a 20% increase over the year is great, but how are they not performing like Moderna's?Pfizer's COVID-19 vaccine generated $7.8 billion in revenue in the second quarter
Shares of Pfizer Inc. undefined were down 0.6% in premarket trading on Wednesday after the company clocked another nearly $8 billion in revenue for the...on.mktw.net